ArticleOphthalmology science2026
Artificial Intelligence-Driven Multimodal Prediction of 10-Year Incident Glaucoma Integrating Genetic and Deep Learning-Derived Imaging Features.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose: Glaucoma is the leading cause of irreversible blindness worldwide. It often remains asymptomatic until advanced stages. Hence, accurate prediction of glaucoma is crucial for timely intervention to prevent vision loss. Design: Population-based prospective cohort study. Subjects: The UK Biobank participants had available color fundus photographs (CFPs), genetic data, and ocular measurements and were free of glaucoma at baseline. The primary analytic cohort for strictly defined incident primary open-angle glaucoma (POAG) comprised 340 cases and 9374 controls; the secondary broadly defined POAG cohort comprised 1241 cases and 34 216 controls. Methods: We developed an interpretable, multimodal machine learning (ML) framework to predict 10-year incident POAG. The framework integrated 5 feature domains: deep learning (DL)-derived CFP features, ocular measurements, polygenic risk scores (PRS), physical and lifestyle factors, and electronic health records. Deep learning-derived imaging features included a CFP glaucoma score and automated vertical cup-to-disc ratio estimation. We benchmarked ten ML algorithms to identify the optimal model. We applied SHapley Additive exPlanations (SHAP) for model interpretability and feature contribution. Main Outcome Measures: The primary outcome was incident POAG defined by International Classification of Diseases 10 code H40.1. A secondary broad POAG phenotype incorporated H40.1, H40.0, and H40.9, while excluding other glaucoma subtypes. Results: In the strictly defined POAG analysis, XGBoost achieved the strongest overall performance for 10-year incident glaucoma prediction, with an area under the receiver operating characteristic curve of 0.927 (95% confidence interval, 0.895-0.959), high sensitivity (0.685) at a fixed specificity of 0.95, and excellent calibration (Brier score, 0.024). The corresponding XGBoost model for broadly defined POAG showed modestly lower discrimination while maintaining similarly strong calibration. Incremental modeling demonstrated that both PRS and DL-derived imaging features provided complementary predictive value beyond traditional clinical factors. SHapley Additive exPlanations analysis identified the CFP DL score, age, PRS, and intraocular pressure as the most influential predictors. A reduced model using only the top 4 SHAP-ranked features retained performance comparable to the all-features multimodal model. Conclusions: Our multimodal ML framework integrating genetic and DL-derived imaging features enables accurate and interpretable prediction of incident POAG. Financial Disclosures: The author has no/the authors have no proprietary or commercial interest in any materials discussed in this article.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.